Riley Lee, APRN
Nurse Practitioner · Leesburg, FLNPI 1265139976
Payments from drug & device makers
Across 263 payments — averaging $64.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulmonx Corporation$10K
- GSK$1K
- AstraZeneca$1K
- Boehringer Ingelheim$574
- Mallinckrodt Hospital Products Inc.$432
- Regeneron Healthcare Solutions, Inc.$413
- plus $3K from 24 others
Across 8 payments — averaging $200.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$2K
What the payments were for
- Consulting fees$7,60045%
- Travel & lodging$1,87911%
- Food & beverage$7,41344%
- Education$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pulmonx Corporation | 27 | $10,452 |
| GSK | 49 | $1,236 |
| AstraZeneca | 16 | $1,199 |
| Boehringer Ingelheim | 18 | $574 |
| Mallinckrodt Hospital Products Inc. | 18 | $432 |
| Regeneron Healthcare Solutions, Inc. | 12 | $413 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $363 |
| ANI Pharmaceuticals, Inc. | 13 | $349 |
| Electromed, Inc. | 37 | $299 |
| Sanofi | 10 | $236 |
| Inari Medical, Inc. | 1 | $198 |
| United Therapeutics Corporation | 4 | $198 |
| Inogen, Inc. | 10 | $142 |
| Actelion Pharmaceuticals US, Inc. | 5 | $131 |
| Fresenius Kabi USA, LLC | 1 | $117 |
| Astellas Pharma US Inc | 1 | $115 |
| Grifols USA, LLC | 4 | $90 |
| Baxter Healthcare | 4 | $71 |
| Merck | 3 | $68 |
| Gilead | 2 | $49 |
| Mylan Specialty L.p. | 2 | $44 |
| Insmed, Inc. | 2 | $40 |
| Bayer | 2 | $39 |
| Vifor Pharma, Inc. | 1 | $28 |
| ZOLL Respicardia, Inc. | 1 | $24 |
| Abiomed | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZEPHYR ENDOBRONCHIAL VALVE$10,141
- CHARTIS CATHETER$3,466
- ZEPHYR DELIVERY CATHETER$3,466
- PULMONX CHARTIS TABLET CONSOLE$3,466
- AIRSUPRA$332
- BREZTRI$321
- AREXVY$228
- FLOWTRIEVER CATHETER, S$198
- CT THROMBECTOMY SYSTEM KIT$198
- FASENRA$127
- TYVASO$124
- Smoflipid$117
- Veozah$115
- ACTHAR$102
How this compares
$16,991 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 32 | $418,744 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 168 | $212,850 |
| Prolastin CAlpha-1-Proteinase Inhibitor | 12 | $103,491 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 69 | $92,233 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 33 | $36,587 |
| Pirfenidone | 11 | $33,000 |
| Spiriva RespimatTiotropium Bromide | 22 | $20,064 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $15,201 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $14,434 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 17 | $13,746 |
| Wixela InhubFluticasone Propion/Salmeterol | 49 | $8,120 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 43 | $5,791 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 117 | $5,131 |
| Advair HfaFluticasone Propion/Salmeterol | 15 | $4,193 |
| Montelukast Sodium | 108 | $1,227 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $574 | $452,55471 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $1,236 | $264,639216 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,199 | $106,66797 claims |
| Grifols USA, LLCProlastin C | $90 | $103,49112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Leesburg
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.